openPR Logo
Press release

Chronic Insomnia Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies - Janssen Research & Development

10-31-2022 12:58 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Chronic Insomnia Market to Witness Growth by (2022-2032),

The Chronic Insomnia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Insomnia pipeline products will significantly revolutionize the Chronic Insomnia market dynamics.

DelveInsight's "Chronic Insomnia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Insomnia, historical and forecasted epidemiology as well as the Chronic Insomnia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Chronic Insomnia market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

To Know in detail about the Chronic Insomnia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Insomnia Market Insights https://www.delveinsight.com/report-store/chronic-insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Chronic Insomnia Overview
Insomnia is the most common sleep disorder with huge socio-economic costs. According to the third edition of the International Classification of Sleep Disorders (ICSD-3), insomnia is characterized by difficulty in either initiating sleep, maintaining sleep continuity, or poor sleep quality. These symptoms occur despite the presence of adequate opportunity and circumstance for sleep and result in daytime dysfunction.

Some of the key facts of the Chronic Insomnia Market Report:
• The Chronic Insomnia market size was valued at USD 333 Million in the year 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• The total diagnosed prevalent population of Chronic Insomnia in the 7MM countries was estimated to be 5,697,127 cases in 2021
• In 2021, there were 474,746 cases in age group of 20-29 years which was the highest in any age group in the United States. This was followed by 421,996 cases in the age group of 30-39 and 40-49 years each in the United States
• Among the EU5 countries, Germany had 207,625 cases of Chronic Insomnia in Females and 199,483 in Males in 2021
• Key Chronic Insomnia Companies: Janssen Research & Development, and others
• Key Chronic Insomnia Therapies: Seltorexant, and others
• The Chronic Insomnia epidemiology based on gender analyzed that Chronic Insomnia is more prominent in females in comparison to males

Get a Free sample for the Chronic Insomnia Market Report
https://www.delveinsight.com/sample-request/chronic-insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Key benefits of the Chronic Insomnia Market report:

1. Chronic Insomnia market report covers a descriptive overview and comprehensive insight of the Chronic Insomnia Epidemiology and Chronic Insomnia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Chronic Insomnia market report provides insights on the current and emerging therapies.
3. Chronic Insomnia market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Chronic Insomnia market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Chronic Insomnia market.

Download the report to understand which factors are driving Chronic Insomnia epidemiology trends @ Chronic Insomnia Epidemiological Insights
https://www.delveinsight.com/sample-request/chronic-insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Chronic Insomnia Market
The dynamics of the Chronic Insomnia market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
Chronic Insomnia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Chronic Insomnia Epidemiology Segmentation:
The Chronic Insomnia market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Chronic Insomnia
• Prevalent Cases of Chronic Insomnia by severity
• Gender-specific Prevalence of Chronic Insomnia
• Diagnosed Cases of Episodic and Chronic Chronic Insomnia

Chronic Insomnia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Insomnia market or expected to get launched during the study period. The analysis covers Chronic Insomnia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Chronic Insomnia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Discover more about therapies set to grab major Chronic Insomnia market share @ Chronic Insomnia market forecast
https://www.delveinsight.com/sample-request/chronic-insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Chronic Insomnia Therapies and Key Companies
• Seltorexant : Janssen Research & Development

Chronic Insomnia Market Drivers
• Increasing Chronic Insomnia Prevalence
• Personalization of Chronic Insomnia therapies

Scope of the Chronic Insomnia Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Chronic Insomnia Companies: Janssen Research & Development, and others
• Key Chronic Insomnia Therapies: Seltorexant, and others
• Chronic Insomnia Therapeutic Assessment: Chronic Insomnia current marketed and Chronic Insomnia emerging therapies
• Chronic Insomnia Market Dynamics: Chronic Insomnia market drivers and Chronic Insomnia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Chronic Insomnia Unmet Needs, KOL's views, Analyst's views, Chronic Insomnia Market Access and Reimbursement

Chronic Insomnia Market Barriers
• Issues with diagnosis and poor knowledge
• Use of off-label drugs
• High economic burden

Table of Contents
1. Chronic Insomnia Market Report Introduction
2. Executive Summary for Chronic Insomnia
3. SWOT analysis of Chronic Insomnia
4. Chronic Insomnia Patient Share (%) Overview at a Glance
5. Chronic Insomnia Market Overview at a Glance
6. Chronic Insomnia Disease Background and Overview
7. Chronic Insomnia Epidemiology and Patient Population
8. Country-Specific Patient Population of Chronic Insomnia
9. Chronic Insomnia Current Treatment and Medical Practices
10. Chronic Insomnia Unmet Needs
11. Chronic Insomnia Emerging Therapies
12. Chronic Insomnia Market Outlook
13. Country-Wise Chronic Insomnia Market Analysis (2019-2032)
14. Chronic Insomnia Market Access and Reimbursement of Therapies
15. Chronic Insomnia Market Drivers
16. Chronic Insomnia Market Barriers
17. Chronic Insomnia Appendix
18. Chronic Insomnia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

To know more about Chronic Insomnia treatment, visit @ Chronic Insomnia Medications https://www.delveinsight.com/sample-request/chronic-insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Related Reports:

Chronic Insomnia Epidemiology
https://www.delveinsight.com/report-store/chronic-insomnia-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Chronic Insomnia Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Chronic Insomnia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Trending Reports by DelveInsight
Ventricular Assist Devices Market
https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Ventricular Assist Devices (VAD) Market Insight, Competitive Landscape and Market Forecast - 2027' report delivers an in-depth understanding of Ventricular Assist Devices and the historical and forecasted Ventricular Assist Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.


Basal Cell Carcinoma (Basal Cell Epithelioma) Market
https://www.delveinsight.com/report-store/basal-cell-carcinoma-basal-cell-epithelioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma), historical and forecasted epidemiology as well as the Basal Cell Carcinoma (Basal Cell Epithelioma) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact

Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Insomnia Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies - Janssen Research & Development here

News-ID: 2784818 • Views:

More Releases from DelveInsight Business Research

Cervical Cancer Market size in 7MM was USD ~900 million in 2023 and expected to increase by 2034, estimates DelveInsight | KEYTRUDA (pembrolizumab), TIVDAK (Tisotumab vedotin-tftv), Volrustomig, PRGN-2009, TECENTRIQ (atezolizumab), AL3818, ANKTIVA (N-803)
Cervical Cancer Market size in 7MM was USD ~900 million in 2023 and expected to …
Cervical Cancer companies are ADC therapeutics, Roche, AstraZeneca, Precigen, Puma Biotechnology, Iovance Bio therapeutics, Nykode Therapeutics, ISA Pharmaceuticals, Regeneron, Transgene, Daiichi Sankyo, Merck Sharp & Dohme, Genmab/Pfizer, Advenchen Laboratories, ImmunityBio, Calithera Biosciences, Seagen, Akeso, Verastem, Iovance Biotherapeutics, Xencor and Many Others. (Albany, USA) DelveInsight's "Cervical Cancer Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Cervical Cancer, historical and forecasted epidemiology as well as the Cervical Cancer market
Bronchial Spasm Market Forecast 2032: FDA, EMA, PDMA Approvals, Epidemiology, Therapies, Clinical Trials and Companies by DelveInsight | Fluticasone propionate/salmeterol, HFA MDI, GSK615915A, albuterol, A006, Epinephrine Inhalation Aerosol
Bronchial Spasm Market Forecast 2032: FDA, EMA, PDMA Approvals, Epidemiology, Th …
The Bronchial Spasm Market is primarily driven by the increasing prevalence of respiratory disorders worldwide. Conditions like asthma and chronic obstructive pulmonary disease (COPD) continue to rise, necessitating effective treatments for bronchial spasms, a common symptom in these conditions. Advancements in diagnostic techniques enable early detection, further fueling market growth. Additionally, continuous research and development efforts lead to the introduction of innovative medications and inhaler technologies, enhancing treatment efficacy and
Biliary Tract Cancer Market Forecast 2034: FDA, EMA, PDMA Approvals, Epidemiology, Therapies, Clinical Trials and Companies by DelveInsight | PEMAZYRE (pemigatinib), IMFINZI (durvalumab), CTX-009, Zanidatamab, more.
Biliary Tract Cancer Market Forecast 2034: FDA, EMA, PDMA Approvals, Epidemiolog …
Biliary Tract Cancer companies are Incyte Corporation, Loxo Oncology, Bayer, Roche, Genentech, QED Therapeutics, Agios Pharmaceuticals, Servier Pharmaceuticals, Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, Eisai, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Zymeworks, BeiGene, and others. (Albany, USA) DelveInsight's "Biliary Tract Cancer Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Biliary Tract Cancer, historical and forecasted epidemiology as well as the Biliary Tract Cancer market trends
Lassa Fever Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Inovio Pharmaceuticals, Irrua Specialist Teaching Hospital, Bernhard Nocht Institute for Tropical Medicine
Lassa Fever Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FD …
The Lassa Fever market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Lassa Fever pipeline products will significantly revolutionize the Lassa Fever market dynamics. DelveInsight's "Lassa Fever Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Lassa Fever, historical and forecasted epidemiology as well as the Lassa Fever market trends in the United

All 5 Releases


More Releases for Chronic

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market Res …
Latest industry research report on: Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
11-10-2016 | Health & Medicine
MRR.biz
Global Chronic, Acute, And Neuropathic Pain Market: Opioids To Remain Most Value …
The research report, titled “Frontier Pharma: Chronic, Acute And Neuropathic Pain - GPCR And Nerve Growth Factor-Based Therapies Offer Strong Potential In Difficult-To-Treat Subtypes,” analyzes the historical as well as the existing performance of this market, emphasizing specifically on various types of therapies applied to treat chronic, acute, and neuropathic pain. According to this 68-page study, the worldwide market for chronic, acute, and neuropathic pain has been observing a significant
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently